胃腸用一般用医薬品の世界市場レポート 2025年

胃腸用一般用医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.2％で、678億8,000万米ドルに成長します。予測期間中の成長は、即効性のある症状緩和オプションに対する需要の高まり、eコマース薬局プラットフォームの浸透拡大、併用OTC治療薬の入手可能性の増加、腸内マイクロバイオームの健康重視の高まり、業界大手によるマーケティングおよび認知向上努力の強化などに起因すると考えられます。予測期間中に予想される主な動向には、即効性制酸剤の製剤化の進展、プロバイオティクスベースのOTC製品の革新、消化器治療へのハーブ成分の取り込み、正確な服用と携帯性のためのパッケージングの改良、徐放性胃腸治療薬の開発などがあります。

消化器系疾患の有病率の増加は、今後数年間における消化器系OTC医薬品市場の拡大を促進すると予想されます。消化器疾患には、胃、腸、関連臓器などの消化管に影響を及ぼすさまざまな疾患が含まれます。このような消化器疾患の増加は主に、腸の健康と消化に悪影響を及ぼす加工食品、低繊維質の食品の消費の増加と関連しています。胃腸薬のOTC医薬品は、胃酸を中和し、腸の機能を調整し、腸の健康をサポートすることで、症状の緩和に役立ちます。胃酸過多、便秘、消化不良といった一般的な問題を迅速かつ簡便に緩和します。例えば、2023年12月、英国の非営利団体IBD Registry Ltd.は、炎症性腸疾患（IBD）と診断された人の数が5,300人を超え、2022年と比べて3,000人以上増加したと報告しました。このように、消化器疾患の発生が増加していることが、胃腸OTC医薬品市場の成長を後押ししています。

胃腸用一般用医薬品市場の主要企業は、市販薬（OTC）のプロトンポンプ阻害薬（PPI）などの先進製品の開発を優先し、酸に関連する症状を効果的かつ長期的に緩和しています。OTC PPIは、処方箋なしで入手できる医薬品のカテゴリーで、胃酸の分泌を抑えることで効果を発揮します。頻繁な胸やけ、胃酸逆流（GERD）、胃潰瘍などの疾患の管理によく使用されます。例えば、2025年3月、日本の製薬会社であるエーザイ株式会社は、パリエットS（ラベプラゾールナトリウム10mg）を処方薬（RX）から一般用医薬品（OTC）に変更する承認を取得しました。これにより、医療用医薬品と同じ有効成分・用量のOTC PPIは日本で初めてとなります。パリエットSは、胃痛、胸やけ、腹部膨満感を1日1回、飲みやすい錠剤で24時間緩和するもので、ライフスタイルや人口動態の変化に伴い、胃酸に関する有効な治療薬への需要が高まっていることに対応するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の胃腸用一般用医薬品：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の胃腸用一般用医薬品市場：成長率分析
• 世界の胃腸用一般用医薬品市場の実績：規模と成長、2019年～2024年
• 世界の胃腸用一般用医薬品市場の予測：規模と成長、2024年～2029年、2034年
• 世界の胃腸用一般用医薬品：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の胃腸用一般用医薬品市場：製品別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 制酸剤
• 下剤
• 下痢止め
• 制吐剤
• その他の製品
• 世界の胃腸用一般用医薬品市場：製剤別、実績と予測、2019年～2024年、2024年～2029年、2034年
• タブレット
• カプセル
• 液体
• その他の製剤
• 世界の胃腸用一般用医薬品市場：適応症別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 胸焼け
• 下痢
• 便秘
• 胃食道逆流症（GERD）
• 吐き気
• 嘔吐
• 乗り物酔い
• その他の適応症
• 世界の胃腸用一般用医薬品市場：流通チャネル別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 直接入札
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界の胃腸用一般用医薬品市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• クリニック
• 在宅ヘルスケア
• その他のエンドユーザー
• 世界の胃腸用一般用医薬品市場、制酸剤の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• プロトンポンプ阻害剤（PPI）
• H2受容体拮抗薬
• 炭酸カルシウム
• 水酸化マグネシウム
• 重炭酸ナトリウム
• 複合制酸剤
• 世界の胃腸用一般用医薬品市場、下剤の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 膨張性下剤
• 刺激性下剤
• 浸透圧性下剤
• 便軟化剤
• 潤滑性下剤
• 世界の胃腸用一般用医薬品市場、下痢止め薬の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ロペラミド
• 次サリチル酸ビスマス
• プロバイオティクス
• 電解質溶液
• 世界の胃腸用一般用医薬品市場、制吐剤の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 抗ヒスタミン薬
• 次サリチル酸ビスマス
• リン酸炭水化物溶液
• ショウガサプリメント
• 世界の胃腸用一般用医薬品市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 消化酵素
• 鎮痙薬
• シメチコン
• ハーブ療法
• 活性炭

第7章 地域別・国別分析

• 世界の胃腸用一般用医薬品市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の胃腸用一般用医薬品市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 胃腸用一般用医薬品市場：競合情勢
• 胃腸用一般用医薬品市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Procter & Gamble Co. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi S.A.
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Reckitt Benckiser Group plc
• Boehringer Ingelheim GmbH
• Haleon plc
• Sandoz AG
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 胃腸用一般用医薬品市場2029年：新たな機会を提供する国
• 胃腸用一般用医薬品市場2029年：新たな機会を提供するセグメント
• 胃腸用一般用医薬品市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gastrointestinal over-the-counter (OTC) drugs are non-prescription medications used to prevent or treat common digestive issues. They provide quick and convenient relief for problems like indigestion and irregular bowel movements, helping to effectively manage mild to moderate digestive discomfort and promote overall digestive health in a safe and accessible manner.

The primary categories of gastrointestinal OTC drugs include antacids, laxatives, anti-diarrheals, anti-emetics, and others. Antacids are drugs that work by neutralizing stomach acid to alleviate symptoms such as heartburn and indigestion. These medications are available in different forms, including tablets, capsules, liquids, and more, and are used for various conditions like heartburn, diarrhea, constipation, gastroesophageal reflux disease (GERD), nausea, vomiting, motion sickness, and others. They are distributed through multiple channels such as direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and more, and are utilized by key end-users, including hospitals, clinics, home healthcare, and others.

The gastrointestinal OTC drugs market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal OTC drugs market statistics, including the gastrointestinal OTC drugs industry global market size, regional shares, competitors with the gastrointestinal OTC drugs market share, detailed gastrointestinal OTC drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the gastrointestinal OTC drugs industry. This gastrointestinal OTC drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastrointestinal over-the-counter (OTC) drugs market size has grown strongly in recent years. It will grow from $45.73 billion in 2024 to $49.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of gastrointestinal disorders, growing consumer inclination toward self-medication, expanded availability of OTC proton pump inhibitors, rising awareness of digestive health, and the growing elderly population susceptible to gastrointestinal issues.

The gastrointestinal over-the-counter (OTC) drugs market size is expected to see strong growth in the next few years. It will grow to $67.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to the rising demand for fast-acting symptom relief options, greater penetration of e-commerce pharmacy platforms, increased availability of combination OTC treatments, growing emphasis on gut microbiome health, and intensified marketing and awareness efforts by major industry players. Key trends anticipated during the forecast period include advancements in the formulation of quick-acting antacids, innovation in probiotic-based OTC products, incorporation of herbal ingredients into digestive treatments, improvements in packaging for accurate dosing and portability, and the development of sustained-release gastrointestinal therapies.

The growing prevalence of digestive disorders is expected to drive the expansion of the gastrointestinal OTC drugs market in the coming years. Digestive disorders encompass various conditions affecting the gastrointestinal tract, including the stomach, intestines, and related organs. This rise in digestive issues is primarily linked to increased consumption of processed, low-fiber foods, which negatively impact gut health and digestion. Gastrointestinal OTC medications help alleviate symptoms by neutralizing stomach acid, regulating bowel function, and supporting gut health. They offer quick and convenient relief for common problems such as acidity, constipation, and indigestion. For example, in December 2023, IBD Registry Ltd., a UK-based non-profit organization, reported that the number of individuals diagnosed with inflammatory bowel disease (IBD) surpassed 5,300, representing a rise of over 3,000 compared to 2022. Thus, the increasing occurrence of digestive disorders is fueling the growth of the gastrointestinal OTC drugs market.

Leading companies in the gastrointestinal OTC drugs market are prioritizing the development of advanced products, such as over-the-counter (OTC) proton pump inhibitors (PPIs), to deliver effective and long-lasting relief from acid-related conditions. OTC PPIs are a category of medications available without a prescription that work by reducing stomach acid production. They are frequently used to manage ailments like frequent heartburn, acid reflux (GERD), and gastric ulcers. For example, in March 2025, Eisai Co., Ltd., a pharmaceutical company based in Japan, received approval to convert its Pariet S (rabeprazole sodium 10 mg) from a prescription (RX) to an over-the-counter (OTC) medication. This marked the first OTC PPI in Japan containing the same active ingredient and dosage as its prescription counterpart. Pariet S is used to treat stomach pain, heartburn, and bloating, offering 24-hour relief through a once-daily, easy-to-swallow tablet, and is designed to meet the increasing demand for effective gastric acid-related therapies prompted by lifestyle and demographic changes.

In June 2022, Glenmark Pharmaceuticals Ltd., a pharmaceutical company based in the U.S., acquired select OTC medications from Wockhardt Ltd. for an undisclosed amount. This acquisition is intended to strengthen Glenmark's OTC product portfolio in the U.S. market, with a particular focus on the gastrointestinal segment. Wockhardt Limited, also based in the U.S., is a pharmaceutical company that produces gastrointestinal OTC drugs.

Major players in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastrointestinal over-the-counter (OTC) drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastrointestinal over-the-counter (OTC) drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal over-the-counter (OTC) drugs market consists of sales of digestive enzymes, probiotics, stool softeners, and fiber supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Over-The-Counter (OTC) Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastrointestinal over-the-counter (otc) drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal over-the-counter (otc) drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal over-the-counter (otc) drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Antacid; Laxatives; Anti-Diarrheal; Anti-Emetics; Other Products
• 2) By Formulation: Tablets; Capsules; Liquids; Other Formulations
• 3) By Indications: Heartburn; Diarrhoea; Constipation; Gastroesophageal Reflux Disease (GERD); Nausea; Vomiting; Motion Sickness; Other Indications
• 4) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Clinics; Home Healthcare; Other End-Users
• Subsegments:
• 1) By Antacid: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists; Calcium Carbonate; Magnesium Hydroxide; Sodium Bicarbonate; Combination Antacids
• 2) By Laxatives: Bulk-Forming Laxatives; Stimulant Laxatives; Osmotic Laxatives; Stool Softeners; Lubricant Laxatives
• 3) By Anti-Diarrheal: Loperamide; Bismuth Subsalicylate; Probiotics; Electrolyte Solutions
• 4) By Anti-Emetics: Antihistamines; Bismuth Subsalicylate; Phosphorated Carbohydrate Solution; Ginger Supplements
• 5) By Other Products: Digestive Enzymes; Antispasmodics; Simethicone; Herbal Remedies; Activated Charcoal
• Companies Mentioned: Pfizer Inc.; Procter & Gamble Co.; Johnson & Johnson; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Characteristics

3. Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends And Strategies

4. Gastrointestinal Over-The-Counter (OTC) Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth Rate Analysis
• 5.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Total Addressable Market (TAM)

6. Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmentation

• 6.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antacid
• Laxatives
• Anti-Diarrheal
• Anti-Emetics
• Other Products
• 6.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Liquids
• Other Formulations
• 6.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Heartburn
• Diarrhoea
• Constipation
• Gastroesophageal Reflux Disease (GERD)
• Nausea
• Vomiting
• Motion Sickness
• Other Indications
• 6.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Tender
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channels
• 6.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Healthcare
• Other End-Users
• 6.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proton Pump Inhibitors (PPIs)
• H2-Receptor Antagonists
• Calcium Carbonate
• Magnesium Hydroxide
• Sodium Bicarbonate
• Combination Antacids
• 6.7. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bulk-Forming Laxatives
• Stimulant Laxatives
• Osmotic Laxatives
• Stool Softeners
• Lubricant Laxatives
• 6.8. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Loperamide
• Bismuth Subsalicylate
• Probiotics
• Electrolyte Solutions
• 6.9. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Bismuth Subsalicylate
• Phosphorated Carbohydrate Solution
• Ginger Supplements
• 6.10. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digestive Enzymes
• Antispasmodics
• Simethicone
• Herbal Remedies
• Activated Charcoal

7. Gastrointestinal Over-The-Counter (OTC) Drugs Market Regional And Country Analysis

• 7.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 8.1. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 9.1. China Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 9.2. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 10.1. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 11.1. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 11.2. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 12.1. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 13.1. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 14.1. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 14.2. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 15.1. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 15.2. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 16.1. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 17.1. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 18.1. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 19.1. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 20.1. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 21.1. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 21.2. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 22.1. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 23.1. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 23.2. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 24.1. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 24.2. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 25.1. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 25.2. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 26.1. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 26.2. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 27.1. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 28.1. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 28.2. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market

• 29.1. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
• 29.2. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape And Company Profiles

• 30.1. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape
• 30.2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Procter & Gamble Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Gastrointestinal Over-The-Counter (OTC) Drugs Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. AstraZeneca plc
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Reckitt Benckiser Group plc
• 31.9. Boehringer Ingelheim GmbH
• 31.10. Haleon plc
• 31.11. Sandoz AG
• 31.12. Bausch Health Companies Inc.
• 31.13. Sun Pharmaceutical Industries Ltd.
• 31.14. Perrigo Company plc
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

34. Recent Developments In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

35. Gastrointestinal Over-The-Counter (OTC) Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer